Cancer charities have condemned a decision not to licence a drug being trialled in our region which extends the life of women suffering the advanced stages of breast cancer.
The National Institute for Clinical Excellence - or NICE - says the drug "Perjeeta" isn't cost effective.
Perjeeta is currently being tested on women through the Christie Hospital in Manchester - but it isn't routinely available on the NHS.
Cancer charities and women taking the drug want NICE to reconsider .
Ashley Derricott reports.
More top news
The insurance broker says it is reviewing 84 branches as 90% of its customers now purchase policies online.
A lively debate between mayoral candidates.
Marcus Willis, who became the toast of last year's Wimbledon, is to appear at this year's Liverpool Hope International Tennis Tournament.